Insiders MacroGenics, Inc.

Equities

MGNX

US5560991094

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
14.82 ^USD	+1.79%		-3.83%	+54.05%

Apr. 26	B. Riley Securities Initiates MacroGenics With Buy Rating, $25 Price Target	MT
Apr. 10	North American Morning Briefing : Traders Await -2-	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Macrogenics Insider Sold Shares Worth $813,501, According to a Recent SEC Filing	Mar. 06	MT
Macrogenics Insider Sold Shares Worth $615,000, According to a Recent SEC Filing	Mar. 06	MT
Macrogenics Insider Sold Shares Worth $1,258,142, According to a Recent SEC Filing	Feb. 07	MT
MacroGenics, Inc. Appoints Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors	23-01-04	CI
Macrogenics, Inc. Approves the Appointment of Margaret Liu, M.D. to Serve as Director	22-12-21	CI
Zymeworks Appoints Paul Moore Chief Scientific Officer	22-06-27	MT
MacroGenics, Inc. Announces Management Changes	22-05-23	CI
MacroGenics Names Eric Risser as COO	22-02-28	MT
MacroGenics, Inc. Announces Promotion of Eric Risser to Chief Operating Officer	22-02-28	CI
MacroGenics, Inc. Announces Resignation of Kenneth Galbraith as A Member of the Board of Directors	22-01-07	CI
MacroGenics, Inc. Announces Paulo Costa, Member of the Board of Directors Will Not Stand for Re-Election as A Director	21-09-27	CI
Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of MacroGenics Stock	21-06-23	MT
Insider Trends: Insider Buying Added to with Purchase of MacroGenics Shares	21-06-17	MT
Insider Trends: Insider Sales Add to 90-Day Trend at MacroGenics	21-03-24	MT
Insider Trends: MacroGenics Insider Sale Scales Back 90-Days of Buys	21-03-24	MT
MacroGenics, Inc. Names Federica O’Brien to its Board of Directors	21-02-11	CI
MacroGenics, Inc. Announces Appointment of Stephen Eck as Senior Vice President, Clinical Development & Chief Medical Officer, Effective Beginning July 1, 2020	20-06-16	CI
MacroGenics, Inc. Announces Resignation of Matt Fust as Director	20-04-03	CI
MacroGenics, Inc. Announces Executive Changes	20-03-04	CI
Matthew Fust Notifies MacroGenics, Inc. That He Will Not Stand for Reelection	20-02-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders MacroGenics, Inc.

Equities

MGNX

US5560991094

Insiders

Filters